Telix Pharmaceuticals cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 1 quarter of results, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2026 |
|---|---|
| Additional items | |
| Beginning Cash Balance | 141.87M |